Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.

UNLIMITED Watchlists, Portfolios, Screeners, and other Barchart tools with Barchart Premier. FREE 30 Day Trial

Faster, Cleaner, Better.

Keryx Biopharm Inc (KERX)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]

[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]

[[ session ]] by (Cboe BZX)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]

[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]

[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]

Balance Sheet for [[ item.sessionDateDisplayLong ]]

Fiscal Year End Date: 12/31

(Values in U.S. thousands)

	06-2007	03-2007	12-2006	09-2006	06-2006
Assets
Current Assets
Cash & Cash Equivalents	24,420	35,471	48,736	67,910	81,058
Marketable Securities	61,162	57,181	63,659	60,853	56,322
Receivables	382	659	525	4,197	5,238
Other current assets	426	829	2,048	0	0
TOTAL	$86,390	$94,140	$114,968	$132,960	$142,618

Non-Current Assets
PPE Net	11,168	10,965	8,489	5,257	2,766
Investments And Advances	2,294	14,708	12,690	11,887	17,309
Intangibles	3,208	3,208	3,208	3,112	3,127
Other Non-Current Assets	344	344	958	973	972
TOTAL	$17,014	$29,225	$25,345	$21,229	$24,174

Total Assets	$103,404	$123,365	$140,313	$154,189	$166,792

Liabilities
Current Liabilities
Accounts payable and accrued liabilities	10,212	13,451	10,460	8,399	6,108
Accrued Expenses	606	320	1,534	592	401
TOTAL	$11,083	$13,968	$12,194	$9,107	$6,693

Non-Current Liabilities
Deferred Revenues	265	197	200	116	184
Other Non-Current Liabilities	4,252	4,275	4,298	4,289	4,292
TOTAL	$4,252	$4,275	$4,298	$4,289	$4,292

Total Liabilities	$15,335	$18,243	$16,492	$13,396	$10,985

Shareholders' Equity
Shares Outstanding, K	43,591	43,565	43,518	43,184	43,184
Common Shares	44	44	44	43	43
Retained earnings	-229,485	-210,025	-188,212	-169,865	-151,872
Other shareholders' equity	-357	-159	-89	-89	-89
TOTAL	$88,069	$105,122	$123,821	$140,793	$155,807

Total Liabilities And Equity	$103,404	$123,365	$140,313	$154,189	$166,792